Article

Oertli launches its SwissTech phaco system at ESCRS

Oertli Instruments AG, Berneck, Switzerland, introduces the SwissTech phaco machine, the successor to its well-established CataRhex phacoemulsification machine, at the European Society of Cataract and Refractive Surgeons (ESCRS) meeting.

Oertli Instruments AG, Berneck, Switzerland, introduces the SwissTech phaco machine, the successor to its well-established CataRhex phacoemulsification machine, at the European Society of Cataract and Refractive Surgeons (ESCRS) meeting.

Company officials report that the portable SwissTech phaco machine brings "higher intelligence" in the performance of cataract surgery. The unit offers little over-engineering and user-proven physical concepts. It eliminates unnecessary features, yet allows for fast, easy-to-learn operation of the machine. Procedures with SwissTech are said to be more economical, at different sites and requiring less space, weighing 5.6 kg (12.3 pounds).

Performance of the SwissTech includes chamber stability at a state-of-the-art level, CMP cool phaco for micro-incision cataract surgery, an occlusion mode, 40 Hz micro pulse, paramount pedal control, and individual programming for nine surgeons. The pressure sensor is a closed system, which eliminates the risk of contamination. The SwissTech also can be extended to posterior segment surgery when in its Vitrex module.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.